Mina T Kelleni

11PUBLICATIONS
0CO-AUTHORS
Wireless communication systems and technologies (incl. microwave and millimetrewave)Medical molecular engineering of nucleic acids and proteinsSoftware quality, processes and metricsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jan 31, 2024
Repurposing metformin to manage idiopathic or long COVID Tinnitus: self-report adopting a pathophysiological and pharmacological approach.

Mina T Kelleni

|Jun 16, 2023
The African Kelleni's roadmap using nitazoxanide and broad-spectrum antimicrobials to abort returning to COVID-19 square one.

Mina T Kelleni

|Mar 17, 2023
Real-world practice of the Egyptian Kelleni's protocol amid changing tropism of SARS-CoV-2 omicron BA.5.2.1.7, XBB 1.5 and CH.1.1 subvariants: a multi-purpose protocol.

Mina T Kelleni

|Nov 25, 2021
NSAIDs and Kelleni's protocol as potential early COVID-19 treatment game changer: could it be the final countdown?

Mina T Kelleni

|Aug 06, 2021
COVID-19, Ebola virus disease, and Nipah virus infection reclassification as novel acute immune dysrhythmia syndrome (n-AIDS): potential crucial role for immunomodulators.

Mina T Kelleni

|Jun 05, 2021
NSAIDs/nitazoxanide/azithromycin repurposed for COVID-19: potential mitigation of the cytokine storm interleukin-6 amplifier via immunomodulatory effects.

Mina T Kelleni

Pageof 2

Frequent Collaborators